The study, sponsored by Ain Shams University, investigates the relationship between sleep EEG changes and language dysfunction in children aged 3 to 10 years. Given the increasing prevalence of language disorders and the potential overlap with epilepsy, this research could address a significant unmet medical need in pediatric neurology. The findings may lead to novel therapeutic strategies, particularly the use of corticosteroids like methylprednisolone and prednisolone, which could enhance language development in affected children. The market for pediatric neurological treatments is growing, and successful outcomes could position Ain Shams University as a key player in this niche, potentially attracting partnerships or licensing opportunities with larger pharmaceutical companies. However, the competitive landscape includes established therapies for language disorders and epilepsy, necessitating careful market positioning and differentiation strategies.